Literature DB >> 7073765

The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.

H J Ahr, L J King, W Nastainczyk, V Ullrich.   

Abstract

The reductive dehalogenation of halothane leading to 2-chloro-1,1,1-trifluoroethane (CTE) and 2-chloro-1,1-difluoroethylene (CDE) has been investigated in vitro using at liver microsomes under anaerobic conditions. The stimulation of NADPH oxidation by halothane as well as the formation of the products were dependent upon cytochrome P450 as indicated by their CO and metyrapone inhibition. After replacement of NADPH by sodium dithionite as a reducing agent CDE was the only product of the enzymatic reaction. The product pattern was influenced by pretreatment with 3-methylcholanthrene, benzo(a)pyrene, phenobarbitone and Arochlor 1254 and by addition of anti-cytochrome P450-PB immunoglobulin. The CTE:CDE ratio was shifted by addition or inhibition of cytochrome b5 and by pH variation indicating a crucial role of the second electron donation to cytochrome P450 in determining the product pattern. The intermediate complex of cytochrome P450 with a Soret band at 470 nm formed with halothane in reduced liver microsomes was shown to decompose spontaneously to give CDE. Therefore we propose the 470 nm peak to represent a cytochrome P450 Fe3+----CHCl-CF3 carbanion complex. From these results a reaction pathway could be derived which includes radical and carbanion intermediates as reactive precursors of CTE and CDE, respectively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073765     DOI: 10.1016/0006-2952(82)90186-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  An in vitro investigation of the reductive metabolism of chloroform.

Authors:  E Testai; S Di Marzio; A di Domenico; A Piccardi; L Vittozzi
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

2.  The mechanism of the suicidal reductive inactivation of microsomal cytochrome P-450 by halothane.

Authors:  M Manno; S Cazzaro; M Rezzadore
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Enzymatic detoxication of DDT to DDD by rat liver: effects of some inducers and inhibitors of cytochrome P-450 enzyme system.

Authors:  S S Zaidi; B D Banerjee
Journal:  Bull Environ Contam Toxicol       Date:  1987-03       Impact factor: 2.151

4.  Attenuation of nitric oxide-stimulated soluble guanylyl cyclase from the rat brain by halogenated volatile anesthetics.

Authors:  Eiji Masaki; Ichiro Kondo
Journal:  J Anesth       Date:  1998-06       Impact factor: 2.078

5.  The role of the liver in the production of free radicals during halothane anaesthesia in the rat. Quantification of N-tert-butyl-alpha-(4- nitrophenyl)nitrone (PBN)-trapped adducts in bile from halothane as compared with carbon tetrachloride.

Authors:  H M Hughes; I M George; J C Evans; C C Rowlands; G M Powell; C G Curtis
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

6.  Acetylene, a mammalian metabolite of 1,1,1-trichloroethane.

Authors:  H Dürk; J L Poyer; C Klessen; H Frank
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  Cosubstrate effects in reductive dehalogenation by Pseudomonas putida G786 expressing cytochrome P-450CAM.

Authors:  M S Logan; L M Newman; C A Schanke; L P Wackett
Journal:  Biodegradation       Date:  1993       Impact factor: 3.909

Review 8.  Carbon-fluorine bond cleavage mediated by metalloenzymes.

Authors:  Yifan Wang; Aimin Liu
Journal:  Chem Soc Rev       Date:  2020-06-08       Impact factor: 54.564

9.  Chemistry and biology of spin-trapping radicals associated with halocarbon metabolism in vitro and in vivo.

Authors:  E G Janzen; H J Stronks; C M Dubose; J L Poyer; P B McCay
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

Review 10.  Metabolism and toxicity of hydrochlorofluorocarbons: current knowledge and needs for the future.

Authors:  M W Anders
Journal:  Environ Health Perspect       Date:  1991-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.